Growth Opportunities and Trends in the Nephrology Drugs Market: Key Insights for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the nephrology drugs market grown in recent years?
The market size for nephrology drugs has been witnessing robust growth in the recent past. The market is predicted to grow from $16.88 billion in 2024, to a size of $17.86 billion in 2025, growing at a compound annual growth rate (CAGR) of 5.8%. This significant increase during the historical period can be attributed to factors such as high prevalence of chronic kidney diseases (CKD), advancements in the development of drugs, heightened awareness and diagnostic capabilities, government-driven initiatives, healthcare policies, and an uptick in diabetes cases.
How is the nephrology drugs market size expected to evolve during the forecast period?
Anticipated to witness robust expansion in the forthcoming years, the nephrology drugs market is projected to reach a whopping $23.04 billion by 2029, proliferating at a compound annual growth rate (CAGR) of 6.6%. This upswing during the prediction period is likely due to an emergence of new therapy techniques and advanced drug inventions, precision and custom-made treatment strategies, a rise in health care expenses, remote patient care along with telehealth, and worldwide health endeavours. A few key trends slated for the forecasting period entail collaborations and partnerships, revolutionary advancements in dialysis technology, enhancements in treatment methodologies, a growing focus on early detection and timely intervention, and the technological amalgamation in the management of nephrology.
Get your nephrology drugs market report here!
https://www.thebusinessresearchcompany.com/report/nephrology-drugs-global-market-report
Which key drivers are propelling the nephrology drugs market’s growth?
The growth of the nephrology drugs market is anticipated to be spurred by the increasing occurrence of chronic kidney disease (CKD). When kidneys are damaged, they lose their ability to effectively filter blood, leading to a gradual build-up of wastes in the body over time. To combat this, nephrology drugs are used to improve kidney function and halt disease progression, which in turn stimulates the nephrology drug market. For example, the Centers for Disease Control and Prevention (CDC), a health protection agency based in the United States, reported in July 2022 that over 37 million people in the United States had been diagnosed with CKD, most prevalently among people aged 65 or older (38 percent). In addition, according to the Kidney Foundation of Canada, a non-profit organization in Canada, 4 million Canadians are dealing with kidney diseases. It identifies 35 percent of diabetic patients as the main contributors to kidney failure. These numbers are predicted to escalate in the coming years. Hence, the escalating incidence of CKD propels the growth of the nephrology drug market.
What are the market segments in the nephrology drugs industry?
The nephrology drugs market covered in this report is segmented –
1) By Drugs: Antihypertensive Agents, Erythropoiesis-Stimulating Agents, Diuretics, ACE Inhibitors, Antidiabetic Agents, Other Drugs
2) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Antihypertensive Agents: Calcium Channel Blockers, Beta-Blockers, Angiotensin II Receptor Blockers (ARBs)
2) By Erythropoiesis-Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa
3) By Diuretics: Loop Diuretics, Thiazide Diuretics, Potassium-Sparing Diuretics
4) By ACE Inhibitors: Lisinopril, Enalapril
5) By Antidiabetic Agents: Metformin, Insulin
6) By Other Drugs: Phosphate Binders, Vitamin D Analogues, Renin Inhibitors
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10076&type=smp
Which leading companies are shaping the growth of the nephrology drugs market?
Major companies operating in the nephrology drugs market include AstraZeneca plc, AbbVie Inc., Akebia Therapeutics Inc., Amgen Inc., F. Hoffmann-La Roche AG, FibroGen Inc., Johnson And Johnson, Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, Boehringer Ingelheim International GmbH, Reata Pharmaceuticals Inc., Ardelyx Inc., Novo Nordisk A/S, Novartis AG, Baxter International Inc., Bristol Myers Squibb Company, Kissei Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals, OPKO Health Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Vifor Pharma Group, Bayer AG, Amicus Therapeutics, Chugai Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Mylan N.V., Endo Pharmaceuticals plc
What key trends are currently impacting the nephrology drugs market’s development?
The emergence of product innovation is becoming a significant trend in the nephrology drug market. To maintain their competitive edge, leading companies in this field are coming up with fresh and innovative products and medicines. As an example, Zydus Lifesciences Limited., a pharmaceutical firm based in India, unveiled Oxemia (desidustat), a new drug for chronic kidney disease (CKD), in March 2022. This oral, small-molecule hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor offers an easy-to-use therapeutic solution for anemia treatment. Following Phase III clinical trials, the Drug Controller General of India provided its stamp of approval, recognizing its attractive safety profiles, better regulation of hepcidin, improved iron mobilization, and LDL-C reductions in CKD patients. By offering an affordable treatment option and seeking to enhance patient quality of life, Zydus is taking strides towards easing the burden of this disease.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10076
Which geographic areas are influencing the growth of the nephrology drugs market?
North America was the largest region in the nephrology drug market in 2024.Europe will be the second-largest growing region in the nephrology drug market in 2024. The regions covered in the nephrology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Drugs For Erectile Dysfunction Global Market Report 2024
Drugs For Benign Prostatic hypertrophy Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
